This is a pilot study to assess the feasibility of using Surescripts refill data during the clinical encounter to improve medication adherence in patients with systemic lupus erythematosus
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
135
Lupus clinic providers will be prompted to assess adherence level using Surescripts refill information and address any adherence barriers that arise during the clinical encounter.
Duke University
Durham, North Carolina, United States
Feasibility as Measured by Number of Participants With EMR (Electronic Medical Record) Documentation of Adherence
Feasibility as measured by documentation of adherence assessment made by provider.
Time frame: 12 weeks
Acceptability as Measured by Provider Survey
Acceptability as measured by provider survey, score range 1-5, with a higher score indicating that the intervention was more acceptable.
Time frame: 12 weeks
Medication Adherence as Determined by Self Report
Time frame: 12 weeks
Percentage of Adherent Participants as Determined by Medication Possession Ratio (MPR)
Medication Possession Ratio (MPR) = days with medication/total days. This will be determined by pharmacy refill data and calculated for 3 months (90 days). An MPR \> or = 80% indicates adherence.
Time frame: Baseline, 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.